No connection

Search Results

ABBV vs MMSI

ABBV
AbbVie Inc.
NEUTRAL
Price
$219.26
Market Cap
$387.52B
Sector
Healthcare
AI Confidence
68%
MMSI
Merit Medical Systems, Inc.
NEUTRAL
Price
$70.54
Market Cap
$4.21B
Sector
Healthcare
AI Confidence
80%

Valuation

P/E Ratio
ABBV
163.63
MMSI
33.12
Forward P/E
ABBV
15.42
MMSI
16.04
P/B Ratio
ABBV
-146.66
MMSI
2.65
P/S Ratio
ABBV
6.5
MMSI
2.77
EV/EBITDA
ABBV
15.27
MMSI
14.4

Profitability

Gross Margin
ABBV
71.46%
MMSI
48.7%
Operating Margin
ABBV
35.5%
MMSI
15.78%
Profit Margin
ABBV
4.0%
MMSI
8.48%
ROE
ABBV
137.96%
MMSI
8.67%
ROA
ABBV
9.59%
MMSI
4.75%

Growth

Revenue Growth
ABBV
9.1%
MMSI
10.9%
Earnings Growth
ABBV
-88.7%
MMSI
38.8%

Financial Health

Debt/Equity
ABBV
--
MMSI
0.52
Current Ratio
ABBV
0.72
MMSI
4.34
Quick Ratio
ABBV
0.47
MMSI
2.79

Dividends

Dividend Yield
ABBV
3.05%
MMSI
--
Payout Ratio
ABBV
490.15%
MMSI
0.0%

AI Verdict

ABBV NEUTRAL

The Advanced Deterministic Scorecard reveals a mixed health profile with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite robust operating margins and consistent revenue growth, the company faces significant headwinds from negative earnings growth, an extremely high P/E ratio, and a dangerously elevated payout ratio. Strong historical price performance and analyst buy sentiment are counterbalanced by bearish insider activity and deteriorating profitability trends. The stock appears to trade at a substantial premium to its intrinsic value, suggesting limited margin of safety.

Strengths
High operating margin (35.50%) indicating strong pricing power and cost control
Consistent revenue growth (9.10% YoY) outpacing sector average
Strong track record of earnings surprises (22 out of 25 quarters beat estimates)
Risks
Extremely high P/E ratio (163.63) vs forward P/E (15.42), suggesting potential overvaluation on trailing basis
Earnings growth collapsing (YoY: -88.70%, Q/Q: -88.10%) indicating severe profitability deterioration
Unsustainable dividend payout ratio (490.15%) threatening dividend security
MMSI NEUTRAL

MMSI presents a dichotomy between strong fundamental growth and poor market sentiment. While the Piotroski F-Score of 4/9 indicates stable but not strong financial health, the company boasts an exceptional track record of earnings beats over 25 quarters and strong YoY earnings growth of 38.8%. However, the stock is currently trading at $70.54, which is a premium to its Intrinsic Value ($62.83) and significantly above its Graham Number ($35.75). Bearish insider activity and a 0/100 technical trend offset the bullish analyst target of $101.18.

Strengths
Exceptional earnings track record with consistent beats over 25 quarters
Strong liquidity position with a Current Ratio of 4.34
Significant earnings growth (38.8% YoY) and positive Q/Q momentum
Risks
Trading at a premium to both Graham Number and Intrinsic Value
Strongly bearish insider sentiment with $5.64M in recent sales
Severe negative technical trend (0/100) and 1Y price decline of 24.4%

Compare Another Pair

ABBV vs MMSI: Head-to-Head Comparison

This page compares AbbVie Inc. (ABBV) and Merit Medical Systems, Inc. (MMSI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile